Literature DB >> 6464798

Adverse drug reactions. An epidemiological study at psychiatric hospitals.

L G Schmidt, R Grohmann, H Helmchen, K Langscheid-Schmidt, B Müller-Oerlinghausen, W Poser, E Rüther, J Scherer, A Strauss, B Wolf.   

Abstract

A drug monitoring system has been established at psychiatric university hospitals in Berlin, Goettingen, and Munich since 1979 in order to investigate adverse reactions to psychotropic drugs. This report describes the system and presents results obtained over 3 years. 504 randomly selected patients were observed by Intensive Drug Monitoring; 75% of them had an adverse drug reaction (ADR) during hospitalization that was assessed as possible, probable, or definite including all grades (I-III) of severity. 5,096 other patients were monitored by Organized Spontaneous Reporting during treatment with psychotropic drugs: ADRs were responsible for drug withdrawal (severity grade III) in about 10% of them. Parkinsonism, psychomotor disturbance, akathisia, delirium, oversedation and increased transaminases were the most frequent ADRs of this kind. The relative frequency of ADRs was calculated, and ADR-profiles established for drugs most frequently withdrawn. The impact of ADRs on ongoing therapy of patients was assessed. Reliable data obtained by drug monitoring systems can be expected to aid in therapeutic decisions in patients with special risks of side effects to psychotropic drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6464798     DOI: 10.1111/j.1600-0447.1984.tb01185.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

1.  Incidence of adverse reactions to commonly prescribed psychopharmacological agents during early phase of therapy.

Authors:  A Kuruvilla; K Kuruvilla
Journal:  Indian J Psychiatry       Date:  1995-07       Impact factor: 1.759

2.  A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country.

Authors:  Jisha Myalil Lucca; Madhan Ramesh; Gurumurthy Parthasarathi; Dushad Ram
Journal:  Psychopharmacol Bull       Date:  2016-03-01

3.  Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach.

Authors:  L G Schmidt; P Dirschedl; R Grohmann; J Scherer; O Wunderlich; B Müller-Oerlinghausen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Assessment of adverse drug reactions in psychiatric hospitals.

Authors:  R Grohmann; H Hippius; B Müller-Oerlinghausen; E Rüther; J Scherer; L G Schmidt; A Strauss; B Wolf
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Reliability of adverse drug reaction assessment in psychiatric inpatients.

Authors:  R Grohmann; P Dirschedl; J Scherer; L G Schmidt; O Wunderlich
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

6.  Adverse effects of clozapine.

Authors:  R Grohmann; E Rüther; N Sassim; L G Schmidt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Adverse drug reactions: a retrospective review of hospitalized patients at a state psychiatric hospital.

Authors:  Courtney A Iuppa; Leigh Anne Nelson; Ellie Elliott; Roger W Sommi
Journal:  Hosp Pharm       Date:  2013-12

Review 8.  Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry.

Authors:  Xinji Zhang; Yuan Zhang; Xiaofei Ye; Xiaojing Guo; Tianyi Zhang; Jia He
Journal:  BMJ Open       Date:  2016-11-23       Impact factor: 2.692

9.  Adverse Drug Reaction Monitoring in a Tertiary Care Psychiatry Setting: A Comparative Study between Inpatients and Outpatients.

Authors:  Tejaswi Gummadi; Virupaksha Shanmugam Harave; Lakshmi Narayan Aiyar; Saraswathy Ganesan RajaLekshmi; Radhika Kunnavil
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

10.  The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.

Authors:  Nobutaka Ayani; Mio Sakuma; Takeshi Morimoto; Toshiaki Kikuchi; Koichiro Watanabe; Jin Narumoto; Kenji Fukui
Journal:  BMC Psychiatry       Date:  2016-08-30       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.